PALEKAR ROHAN

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
PALEKAR ROHAN's trades of 89Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US 89Bio Inc (ETNB)
Transaction date
Purchase
Price
311.23
Quantity 54,578 +29.8%
Value US$394,963
US 89Bio Inc (ETNB)
Transaction date
Purchase
Price
371.42
Quantity 47,722 +15.3%
Value US$1,290,711
US 89Bio Inc (ETNB)
Transaction date
Planned sale
Price
401.47
Quantity 48,200 -37.3%
Value US$1,115,197
US 89Bio Inc (ETNB)
Transaction date
Proposed sale
Price
10.91
Quantity 52,718
Value US$574,933
US 89Bio Inc (ETNB)
Transaction date
Planned sale
Price
10.76
Quantity 4,477 -0.9%
Value US$48,173
US 89Bio Inc (ETNB)
Transaction date
Proposed sale
Price
10.76
Quantity 4,477
Value US$48,173
US 89Bio Inc (ETNB)
Transaction date
Planned sale
Price
11.20
Quantity 50,000 -14.2%
Value US$560,000
US 89Bio Inc (ETNB)
Transaction date
Proposed sale
Price
11.20
Quantity 50,000
Value US$560,010
US 89Bio Inc (ETNB)
Transaction date
Planned sale
Price
20.00
Quantity 15,000 -5.0%
Value US$300,000
US 89Bio Inc (ETNB)
Transaction date
Proposed sale
Price
20.00
Quantity 15,000
Value US$300,000
US 89Bio Inc (ETNB)
Transaction date
Planned sale
Price
16.00
Quantity 15,000 -5.3%
Value US$240,000
US 89Bio Inc (ETNB)
Transaction date
Planned purchase
Price
6.14
Quantity 2,500 +5.8%
Value US$15,350
US 89Bio Inc (ETNB)
Transaction date
Planned purchase
Price
7.50
Quantity 5,000 +13.0%
Value US$37,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-10 2024-12-06
US 89Bio Inc (ETNB)
B Purchase
54,578 +29.8%
311.23
US$394,963 		54,578 +29.8% 311.23 US$394,963
2024-11-25 2024-11-22
US 89Bio Inc (ETNB)
B Purchase
47,722 +15.3%
371.42
US$1,290,711 		47,722 +15.3% 371.42 US$1,290,711
2024-04-03 2024-04-01
US 89Bio Inc (ETNB)
PlS Planned sale
48,200 -37.3%
401.47
US$1,115,197 		48,200 -37.3% 401.47 US$1,115,197
2024-04-01 2024-04-01
US 89Bio Inc (ETNB)
PrS Proposed sale
52,718
10.91
US$574,933 		52,718 10.91 US$574,933
2024-02-28 2024-02-26
US 89Bio Inc (ETNB)
PlS Planned sale
4,477 -0.9%
10.76
US$48,173 		4,477 -0.9% 10.76 US$48,173
2024-02-26 2024-02-26
US 89Bio Inc (ETNB)
PrS Proposed sale
4,477
10.76
US$48,173 		4,477 10.76 US$48,173
2024-01-03 2023-12-29
US 89Bio Inc (ETNB)
PlS Planned sale
50,000 -14.2%
11.20
US$560,000 		50,000 -14.2% 11.20 US$560,000
2023-12-29 2023-12-29
US 89Bio Inc (ETNB)
PrS Proposed sale
50,000
11.20
US$560,010 		50,000 11.20 US$560,010
2023-06-07 2023-06-05
US 89Bio Inc (ETNB)
PlS Planned sale
15,000 -5.0%
20.00
US$300,000 		15,000 -5.0% 20.00 US$300,000
2023-06-05 2023-06-05
US 89Bio Inc (ETNB)
PrS Proposed sale
15,000
20.00
US$300,000 		15,000 20.00 US$300,000
2023-03-27 2023-03-23
US 89Bio Inc (ETNB)
PlS Planned sale
15,000 -5.3%
16.00
US$240,000 		15,000 -5.3% 16.00 US$240,000
2022-01-31 2022-01-28
US 89Bio Inc (ETNB)
PP Planned purchase
2,500 +5.8%
6.14
US$15,350 		2,500 +5.8% 6.14 US$15,350
2022-01-31 2022-01-27
US 89Bio Inc (ETNB)
PP Planned purchase
5,000 +13.0%
7.50
US$37,500 		5,000 +13.0% 7.50 US$37,500